TP53 and breast cancer: We have demonstrated, for the first time, that AA supplementation inhibits the proliferation of Her2-overexpressing p53 mutant breast cancer cell lines at subtoxic concentrations that enhance dox cytotoxicity, with relative sparing of cardiomyocytes.